Literature DB >> 22977483

IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions.

Maria Magdalena Koczorowska1, Anna Kwasniewska, Anna Gozdzicka-Jozefiak.   

Abstract

Human papillomavirus (HPV) plays a crucial role in cervical cancer etiology. However, not all HPV-infected women develop cancer, indicating that additional cellular factors facilitate carcinogenesis. The aim of this study was to analyze the expression profile of insulin-like growth factor 1 (IGF1) isoforms in the context of FOX2, SP1 and IGF1 receptor (IGF1R) expression during HPV-dependent cervical carcinogenesis. One hundred and nine epithelial tissue samples from women with pre-cancerous and cancer lesions of the cervix were analyzed. HPV DNA was identified by PCR, and real-time PCR was used to quantify the expression levels of the analyzed genes. All IGF1 mRNA splicing isoforms were up-regulated in pre-cancerous cells, and a shift in the balance towards mitogenic IGF1Eb was observed in the cancer samples. IGF1 expression was controlled mainly by the P1 promoter, and an increase in P2 usage was observed in the cancer. Correlations between IGF1 mRNA splicing isoforms and the FOX2 splicing factor, as well as P1/P2 activity and SP1 transcription factor expression levels were detected. No correlation was observed between the expression of IGF1 and its receptor IGF1R. Our results suggest that IGF1, in particular its splicing profile, may be an additional prognostic factor in cervical carcinogenesis.

Entities:  

Year:  2010        PMID: 22977483      PMCID: PMC3440635          DOI: 10.3892/etm.2010.174

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  39 in total

Review 1.  Overview of the IGF-I system.

Authors:  Pinchas Cohen
Journal:  Horm Res       Date:  2006-03-02

2.  Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro.

Authors:  A Philippou; E Papageorgiou; G Bogdanis; A Halapas; A Sourla; M Maridaki; N Pissimissis; M Koutsilieris
Journal:  In Vivo       Date:  2009 Jul-Aug       Impact factor: 2.155

3.  Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.

Authors:  Joan M Carboni; Adrian V Lee; Darryl L Hadsell; Bruce R Rowley; Francis Y Lee; David K Bol; Amy E Camuso; Marco Gottardis; Ann F Greer; Ching Ping Ho; Warren Hurlburt; Aixin Li; Mark Saulnier; Upender Velaparthi; Cindy Wang; Mei-Li Wen; Richard A Westhouse; Mark Wittman; Kurt Zimmermann; Brent A Rupnow; Tai W Wong
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

4.  Serum and tissue levels of insulin-like growth factor-I in women with dysplasia and HPV-positive cervical cancer.

Authors:  Agata Jozefiak; Joanna Pacholska-Bogalska; Magdalena Myga-Nowak; Witold Kedzia; Anna Kwasniewska; Michal Luczak; Helena Kedzia; Anna Gozdzicka-Jozefiak
Journal:  Mol Med Rep       Date:  2008 Mar-Apr       Impact factor: 2.952

5.  Up-regulated expression of Sp1 protein coincident with a viral protein in human and mouse differentiating keratinocytes may act as a cell differentiation marker.

Authors:  Bo Li; Xiao Wang; Fang Zhou; Nicholas A Saunders; Ian H Frazer; Kong-Nan Zhao
Journal:  Differentiation       Date:  2008-07-30       Impact factor: 3.880

6.  Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity.

Authors:  Manlio Vinciguerra; Maria Paola Santini; William C Claycomb; Andreas G Ladurner; Nadia Rosenthal
Journal:  Aging (Albany NY)       Date:  2009-12-10       Impact factor: 5.682

7.  Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens.

Authors:  Hiroyuki Kuramoto; Atsushi Hongo; Yi-xuan Liu; Yojiro Ojima; Keiichiro Nakamura; Noriko Seki; Junichi Kodama; Yuji Hiramatsu
Journal:  Acta Med Okayama       Date:  2008-08       Impact factor: 0.892

Review 8.  The insulin-like growth factor system and cancer.

Authors:  Derek LeRoith; Charles T Roberts
Journal:  Cancer Lett       Date:  2003-06-10       Impact factor: 8.679

9.  Validation of reference genes in cervical cell samples from human papillomavirus-infected and -uninfected women for quantitative reverse transcription-PCR assays.

Authors:  Ibrahim I Daud; Mark E Scott
Journal:  Clin Vaccine Immunol       Date:  2008-07-16

10.  RNA splicing factors regulated by HPV16 during cervical tumour progression.

Authors:  Sarah Mole; Melanie McFarlane; Thanaporn Chuen-Im; Steven G Milligan; David Millan; Sheila V Graham
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

View more
  12 in total

Review 1.  The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.

Authors:  Anastassios Philippou; Maria Maridaki; Spiros Pneumaticos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-05-07       Impact factor: 6.354

2.  Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C.

Authors:  Aldona Kasprzak; Agnieszka Adamek; Wiesława Przybyszewska; Przemysław Pyda; Jacek Szmeja; Agnieszka Seraszek-Jaros; Agata Lanzafame; Anna Surdacka; Iwona Mozer-Lisewska; Maria Koczorowska
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  IPF pathogenesis is dependent upon TGFβ induction of IGF-1.

Authors:  Danielle M Hernandez; Jeong-Han Kang; Malay Choudhury; Mahefatiana Andrianifahanana; Xueqian Yin; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

4.  Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.

Authors:  Mauro De Santi; Giosuè Annibalini; Elena Barbieri; Anna Villarini; Luciana Vallorani; Serena Contarelli; Franco Berrino; Vilberto Stocchi; Giorgio Brandi
Journal:  Cell Oncol (Dordr)       Date:  2015-12-23       Impact factor: 6.730

Review 5.  IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).

Authors:  Julia Durzyńska
Journal:  Oncol Rep       Date:  2014-09-19       Impact factor: 3.906

6.  Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer.

Authors:  Anastassios Philippou; Athanasios Armakolas; Michael Koutsilieris
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

7.  Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancer.

Authors:  Aldona Kasprzak; Witold Szaflarski; Jacek Szmeja; Małgorzata Andrzejewska; Wiesława Przybyszewska; Maria Koczorowska; Michał Drews; Elżbieta Kaczmarek
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29

8.  IGF expression in HPV-related and HPV-unrelated human cancer cells.

Authors:  Julia Durzyńska; Elisabeth Barton
Journal:  Oncol Rep       Date:  2014-07-11       Impact factor: 3.906

9.  IGF-IEc expression is increased in secondary compared to primary foci in neuroendocrine neoplasms.

Authors:  Krystallenia I Alexandraki; Anastassios Philippou; Georgios Boutzios; Irini Theohari; Michael Koutsilieris; Ioanna Kassiani Delladetsima; Gregory A Kaltsas
Journal:  Oncotarget       Date:  2017-09-08

10.  Immunohistochemical expression of insulin-like growth factor-1Ec in primary endometrial carcinoma: Association with PTEN, p53 and survivin expression.

Authors:  Aggelis Stavropoulos; Michail Varras; Anastassios Philippou; Thivi Vasilakaki; Viktoria-Konstantina Varra; Fani-Niki Varra; Aikaterini Tsavari; Andreas C Lazaris; Michael Koutsilieris
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.